Research progress on the synthesis and pharmacology of 1,3,4-oxadiazole and 1,2,4-oxadiazole derivatives: a mini review

References

• Boström J, Hogner A, Llinàs A, et al. Oxadiazoles in medicinal chemistry. J Med Chem 2012;55:1817–30.
   PubMed Web of Science ®Google Scholar
• Patani GA, LaVoie EJ. Bioisosterism: a rational approach in drug design. Chem Rev 1996;96:3147–76.
   PubMed Web of Science ®Google Scholar
• Aboraia AS, Abdel-Rahman HM, Mahfouz NM, EL-Gendy MA. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents. Bioorg Med Chem 2006;14:1236–46.
   PubMed Web of Science ®Google Scholar
• Adib M, Kesheh MR, Ansari S, Bijanzadeh HR. Reaction between N-Isocyaniminotrip -henylphosphorane, aldehydes, and carboxylic acids: a one-pot and three-componen synthesis of 2-Aryl-5-hydroxyalkyl-1,3,4-oxadiazoles. Synlett 2009;2009:1575–8.
   Google Scholar
• Chen Q, Zhu XL, Jiang LL, Liu ZM, et al. Synthesis, antifungal activity and CoMFA analysis of novel 1,2,4-triazolo[1,5-a]pyrimidine derivatives. Eur J Med Chem 2008;43:595–603.
   PubMed Web of Science ®Google Scholar
• Kadi AA, El-Brollosy NR, Al-Deeb OA, et al. Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1,3,4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1,3,4- thiadiazoles. Eur J Med Chem 2007;42:235–42.
   PubMed Web of Science ®Google Scholar
• Palaska E, Sahin G, Kelicen P, et al. Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazides, 1,3,4-oxadiazoles, 1,3,4- thiadiazoles and 1,2,4-triazole-3-thiones. Farmaco 2002;57:101–7.
   PubMedGoogle Scholar
• Alisi IO, Uzairu A, Abechi SE. Free radical scavenging mechanism of 1,3,4-oxadiazole derivatives: thermodynamics of OH and N–H bond cleavage. Heliyon 2020;6:e03683.
   PubMed Web of Science ®Google Scholar
• Zarghi A, Tabatabai SA, Faizi M, et al. Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazoles. Bioorg Med Chem Lett 2005;15:1863–5.
   PubMed Web of Science ®Google Scholar
• Chandrakantha B, Shetty P, Nambiyar V, et al. Synthesis, characterization and biological activity of some new 1,3,4-oxadiazole bearing 2-flouro-4-methoxy phenyl moiety. Eur J Med Chem 2010;45:1206–10.
   PubMed Web of Science ®Google Scholar
• Ustabaş R, Süleymanoğlu N, Ünver Y, Direkel Ş. 5-(4-Bromobenzyl)-4-(4-(5-phenyl-1,3,4-oxadiazole-2-yl)phenyl)-2,4-dihydro-3H-1,2,4-triazole-3-one: synthesis, characterization, DFT study and antimicrobial activity. J Mol Struct 2020;1214:128217.
   Web of Science ®Google Scholar
• Kashid BB, Salunkhe PH, Dongare BB, et al. Synthesis of novel of 2,5-disubstituted 1,3,4-oxadiazole derivatives and their in vitro anti-inflammatory, anti-oxidant evaluation, and molecular docking study. Bioorg Med Chem Lett 2020;30:127136.
   PubMed Web of Science ®Google Scholar
• Alam MM, Almalki AS, Neamatallah T, et al. Synthesis of New 1, 3, 4-Oxadiazole-incorporated 1, 2, 3-Triazole moieties as potential anticancer agents targeting thymidylate synthase and their docking studies. Pharmaceuticals 2020;13:390.
   Web of Science ®Google Scholar
• Alam MM, Nazreen S, Almalki ASA, et al. Naproxen based 1,3,4-oxadiazole derivatives as EGFR inhibitors: design, synthesis, anticancer, and computational studies. Pharmaceuticals 2021;14:870.
   Web of Science ®Google Scholar
• Almalki ASA, Nazreen S, Malebari AM, et al. Synthesis and biological evaluation of 1,2,3-triazole tethered thymol-1,3,4-oxadiazole derivatives as anticancer and antimicrobial agents. Pharmaceuticals 2021;14:866.
   Web of Science ®Google Scholar
• Ullah H, Rahim F, Taha M, et al. Aryl-oxadiazole Schiff bases: synthesis, α-glucosidase in vitro inhibitory activity and their in silico studies. Arabian J Chem 2020;13:4904–15.
   Web of Science ®Google Scholar
• Ono Y, Ninomiya M, Kaneko D, et al. Design and synthesis of quinoxaline-1,3,4-oxadiazole hybrid derivatives as potent inhibitors of the anti-apoptotic Bcl-2 protein. Bioorg Chem 2020;104:104245.
   PubMed Web of Science ®Google Scholar
• Said MF, Georgey HH, Mohammed ER. Synthesis and computational studies of novel fused pyrimidinones as a promising scaffold with analgesic, anti-inflammatory and COX inhibitory potential. Eur J Med Chem 2021;224:113682.
   PubMed Web of Science ®Google Scholar
• Chortani S, Edziri H, Manachou M, et al. Novel 1,3,4-oxadiazole linked benzopyrimidinones conjugates: synthesis, DFT study and antimicrobial evaluation. J Mol Struct 2020;1217:128357.
   Web of Science ®Google Scholar
• Bitla S, Sagurthi SR, Dhanavath R, et al. Design and synthesis of Triazole conjugated novel 2,5-diaryl substituted 1,3,4-oxadiazoles as potential antimicrobial and anti-fungal agents. J Mol Struct 2020;1220:128705.
   Web of Science ®Google Scholar
• Ningegowda R, Chandrashekharappa S, Singh V, et al. Design, synthesis and characterization of novel 2-(2,3-dichlorophenyl)-5-aryl-1,3,4-oxadiazole derivatives for their anti-tubercular activity against Mycobacterium tuberculosis. Chem Data Collect 2020;28:100431.
   Google Scholar
• Nagesh Khadri MJ, Bushra Begum A, Sunil MK, Khanum SA. Synthesis, docking and biological evaluation of thiadiazole and oxadiazole derivatives as antimicrobial and antioxidant agents. Results Chem 2020;2:100045.
   Google Scholar
• Bajaj S, Kumar MS, Tinwala H, YC M. Design, synthesis, modelling studies and biological evaluation of 1,3,4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme. Bioorg Chem 2021;111:104873.
   PubMed Web of Science ®Google Scholar
• Fang LC, Tian JP, Zhang KX, et al. Discovery of 1,3,4-oxadiazole derivatives as potential antitumor agents inhibiting the programmed cell death-1/programmed cell death-ligand 1 interaction. Bioorg Med Chem 2021;46:116370.
   PubMed Web of Science ®Google Scholar
• Ribeiro JLS, Soares JCAV, Portapilla GB, et al. Trypanocidal activity of new 1,6-diphenyl-1H-pyrazolo[3,4-b]pyridine derivatives: synthesis, in vitro and in vivo studies. Bioorg Med Chem 2021;29:115855.
   PubMedGoogle Scholar
• Mehandi R, Arif R, Rana M, et al. Synthesis, characterization, DFT calculation, antifungal, antioxidant, CT-DNA/pBR322 DNA interaction and molecular docking studies of heterocyclic analogs. J Mol Struct 2021;1245:131248.
   Web of Science ®Google Scholar
• Dhonnar SL, More RA, Adole VA, et al. Synthesis, spectral analysis, antibacterial, antifungal, antioxidant and hemolytic activity studies of some new 2,5-disubstituted-1,3,4-oxadiazoles. J Mol Struct 2022;1253:132216.
   Web of Science ®Google Scholar
• Izgi S, Sengul IF, Şahin E, et al. Synthesis of 7-azaindole based carbohydrazides and 1,3,4-oxadiazoles; antioxidant activity, α-glucosidase inhibition properties and docking study. J Mol Struct 2022;1247:131343.
   Web of Science ®Google Scholar
• Gond MK, Shukla A, Pandey SK, et al. Mn(II) catalyzed synthesis of 5(4-hydroxyphenyl)-2- (N-phenylamino)-1,3,4-oxadiazole: crystal structure, DFT, molecular docking, Hirshfeld surface analysis, and in vitro anticancer activity on DL cells. J Mol Struct 2022;1249:131547.
   Web of Science ®Google Scholar
• Jyothi M, Sherapura A, Khamees HA, et al. Synthesis, structure analysis, DFT calculations and energy frameworks of new coumarin appended oxadiazoles, to regress ascites malignancy by targeting VEGF me diated angiogenesis. J Mol Struct 2022;1252:132173.
   Web of Science ®Google Scholar
• Tok F, Uğraş Z, Sağlık BN, et al. Novel 2,5-disubstituted-1,3,4-oxadiazole derivatives as MAO-B inhibitors: synthesis, biological evaluation and molecular modeling studies. Bioorg Chem 2021;112:104917.
   PubMed Web of Science ®Google Scholar
• Duhan M, Kumar P, Sindhu J, et al. Exploring biological efficacy of novel benzothiazole linked 2,5-disubstituted-1,3,4- oxadiazole hybrids as efficient α-amylase inhibitors: synthesis, characterization, inhibition, molecular docking, molecular dynamics and Monte Carlo based QSAR studies. Comput Biol Med 2021;138:104876.
   PubMed Web of Science ®Google Scholar
• Zhao TM, Yang Y, Yang J, et al. Harmine-inspired design and synthesis of benzo[d]imidazo[2,1-b]thiazole derivatives bearing 1,3,4-oxadiazole moiety as potential tumor suppressors. Bioorg Med Chem 2021;46:116367.
   PubMed Web of Science ®Google Scholar
• Tripathi A, Choubey PK, Sharma P, et al. Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer’s disease. Bioorg Chem 2020;95:103506.
   PubMed Web of Science ®Google Scholar
• Sharma V, Kumar R, Angeli A, et al. Tail approach synthesis of novel benzenesulfonamides incorporating 1,3,4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes. Eur J Med Chem 2020;193:112219.
   PubMed Web of Science ®Google Scholar
• Hamdani SS, Khan BA, Hameed S, et al. Synthesis and evaluation of novel S-benzyl- and S-alkylphthalimide- oxadiazole -benzenesulfonamide hybrids as inhibitors of dengue virus protease. Bioorg Chem 2020;96:103567.
   PubMed Web of Science ®Google Scholar
• Javid N, Munir R, Chaudhry F, et al. Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition. Bioorg Chem 2020;99:103852.
   PubMed Web of Science ®Google Scholar
• Yu W, Cheng LP, Pang W, Guo LL. Design, synthesis and biological evaluation of novel 1,3,4-oxadiazole derivatives as potent neuraminidase inhibitors. Bioorg Med Chem 2022;57:116647.
   PubMed Web of Science ®Google Scholar
• Taha M, Rahim F, Zaman K, et al. Synthesis, α-glycosidase inhibitory potential and molecular docking study of benzimidazole derivatives. Bioorg Chem 2020;95:103555.
   PubMed Web of Science ®Google Scholar
• Shanmugam MK, Rangappa S, Metri PK, et al. Exploring the newer oxadiazoles as real inhibitors of human SIRT2 in hepatocellular cancer cells. Bioorg Med Chem Lett 2020;30:127330.
   PubMed Web of Science ®Google Scholar
• Kotla R, Murugulla AC, Ruddarraju R, et al. Synthesis and biological evaluation of 1,3,4-oxadiazole fused tetrazole amide derivatives as anticancer agents. Chem Data Collect 2020;30:100548.
   Google Scholar
• Singh RB, Das N, Singh GK, et al. Synthesis and pharmacological evaluation of 3-[5-(aryl-[1,3,4]oxadiazole-2-yl]-piperidine derivatives as anticonvulsant and antidepressant agents. Arabian J Chem 2020;13:5299–5311.
   Web of Science ®Google Scholar
• Kaneko D, Ninomiya M, Yoshikawa R, et al. Synthesis of [1,2,4]triazolo[4,3-α]quinoxaline-1,3,4- oxadiazole derivatives as potent antiproliferative agents via a hybrid pharmacophore approach. Bioorg Chem 2020;104:104293.
   PubMed Web of Science ®Google Scholar
• Sreenivasulu R, Tej MB, Jadav SS, Sujitha P, et al. Synthesis, anticancer evaluation and molecular docking studies of 2,5-bis(indolyl)-1,3,4- oxadiazoles, Nortopsentin analogues. J Mol Struct 2020;1208:127875.
   Web of Science ®Google Scholar
• Kumar D, Kumar RR, Pathania S, et al. Investigation of indole functionalized pyrazoles and oxadiazoles as anti-inflammatory agents: synthesis, in-vivo, in-vitro and in-silico analysis. Bioorg Chem 2021;114:105068.
   PubMed Web of Science ®Google Scholar
• Tolba MS, Sayed AM, Sayed M, Ahmed M. Design, synthesis, biological evaluation, and molecular docking of some new Thieno[2,3-d] pyrimidine derivatives. J Mol Struct 2021;1246:131179.
   Web of Science ®Google Scholar
• Wu ZB, Yang WQ, Hou ST, et al. In vivo antiviral activity and disassembly mechanism of novel 1-phenyl-5-amine-4-pyrazole thioether derivatives against Tobacco mosaic virus. Pestic Biochem Physiol 2021;173:104771.
   PubMed Web of Science ®Google Scholar
• Abbas AH, Mahmood AAR, Tahtamouni LH, et al. New picolinic acid derivatives: synthesis, docking study and anti-EGFR kinase inhibitory effect. Mater Today Proc 2021;5:13–14.
   Google Scholar
• Vanjare BD, Choi NG, Mahajan PG, et al. Novel 1,3,4-oxadiazole compounds inhibit the tyrosinase and melanin level: synthesis, in-vitro, and in-silico studies. Bioorg Med Chem 2021;41:116222.
   PubMed Web of Science ®Google Scholar
• Omar AME, AboulWafa OM, Amr ME, El-Shoukrofy MS. Antiproliferative activity, enzymatic inhibition and apoptosis-promoting effects of benzoxazole-based hybrids on human breast cancer cells. Bioorg Chem 2021;109:104752.
   PubMed Web of Science ®Google Scholar
• Çevik UA, Celik I, Işık A, et al. Synthesis, molecular modeling, quantum mechanical calculations and ADME estimation studies of benzimidazole-oxadiazole derivatives as potent antifungal agents. J Mol Struct 2022;1252:132095.
   Web of Science ®Google Scholar
• Alfayomy AM, Abdel-Aziz SA, Marzouk AA, Shaykoon MSA, et al. Design and synthesis of pyrimidine-5-carbonitrile hybrids as COX-2 inhibitors: anti-inflammatory activity, ulcerogenic liability, histopathological and docking studies. Bioorg Chem 2021;108:104555.
   PubMed Web of Science ®Google Scholar
• El-Etrawy AS, Sherbiny FF. Design, synthesis, biological assessment and molecular docking studies of some new 2-Thioxo-2,3-dihydropyrimidin-4(1H)-ones as potential anticancer and antibacterial agents. J Mol Struct 2021;1225:129014.
   Web of Science ®Google Scholar
• El-Etrawy AS, Sherbiny FF. Design, synthesis, biological evaluation and molecular modeling investigation of new N’-(2-Thiouracil-5-oyl) hydrazone derivatives as potential anti-breast cancer and anti-bacterial agents. J Mol Struct 2021;1232:129993.
   Web of Science ®Google Scholar
• Fahim AM, Farag AM, Mermer A, et al. Synthesis of novel β-lactams: antioxidant activity, acetylcholinesterase inhibition and computational studies. J Mol Struct 2021;1233:130092.
   Web of Science ®Google Scholar
• Rashad AY, Kassab SE, Daabees HG, et al. Febuxostat-based amides and some derived heterocycles targeting xanthine oxidase and COX inhibition. Synthesis, in vitro and in vivo biological evaluation, molecular modeling and in silico ADMET studies. Bioorg Chem 2021;113:104948.
   PubMed Web of Science ®Google Scholar
• Hagras M, Salama EA, Sayed AM, et al. Oxadiazolylthiazoles as novel and selective antifungal agents. Eur J Med Chem 2020;189:112046.
   PubMed Web of Science ®Google Scholar
• Alzhrani ZMM, Alam MM, Neamatallah T, Nazreen S. Design, synthesis and in vitro antiproliferative activity of new thiazolidinedione-1,3,4-oxadiazole hybrids as thymidylate synthase inhibitors. J Enzyme Inhib Med Chem 2020;35:1116–1123.
   PubMed Web of Science ®Google Scholar
• Wang J, Ansari MF, Zhou CH. Unique para-aminobenzenesulfonyl oxadiazoles as novel structural potential membrane active antibacterial agents towards drug-resistant methicillin resistant Staphylococcus aureus. Bioorg Med Chem Lett 2021;41:127995.
   PubMed Web of Science ®Google Scholar
• Gu DY, Cheng G, Zhang MM, et al. Discovery of 2-(5-(quinolin-6-yl)-1,3,4-oxadiazol-2-yl)acetamide derivatives as novel PI3Kα inhibitors via docking-based virtual screening. Bioorg Med Chem 2021;29:115863.
   PubMedGoogle Scholar
• Wang AP, Xu SJ, Chai Y, et al. Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents. Bioorg Med Chem 2022;53:116529.
   PubMed Web of Science ®Google Scholar
• Gontijo TB, Lima PS, Icimoto MY, et al. Cathepsin K inhibitors based on 2-amino-1,3,4-oxadiazole derivatives. Bioorg Chem 2021;109:104662.
   PubMed Web of Science ®Google Scholar
• El Mansouri AE, Oubella A, Mehdi A, et al. Design, synthesis, biological evaluation and molecular docking of new 1,3,4-oxadiazole homonucleosides and their double-headed analogs as antitumor agents. Bioorg Chem 2021;108:104558.
   PubMed Web of Science ®Google Scholar
• Naaz F, Khan A, Kumari A, et al. 1,3,4-oxadiazole conjugates of capsaicin as potent NorA efflux pump inhibitors of Staphylococcus aureus. Bioorg Chem 2021;113:105031.
   PubMed Web of Science ®Google Scholar
• Meng XD, Gao LX, Wang ZJ, et al. Synthesis and biological evaluation of 2,5-diaryl-1,3,4-oxadiazole derivatives as novel Src homology 2 domain-containing protein tyrosine phosphatase 2 (SHP2) inhibitors. Bioorg Chem 2021;116:105384.
   PubMed Web of Science ®Google Scholar
• Ergül AG, Maz TG, Kretzer C, et al. Novel potent benzimidazole-based microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C4 synthase. Eur J Med Chem 2022;231:114167.
   PubMed Web of Science ®Google Scholar
• Loboda KB, Valjavec K, Štampar M, et al. Design and synthesis of 3,5-substituted 1,2,4-oxadiazoles as catalytic inhibitors of human DNA topoisomerase IIα. Bioorg Chem 2020;99:103828.
   PubMed Web of Science ®Google Scholar
• Zhang YY, Zhang QQ, Zhang J, et al. Synthesis and evaluation of 1,2,4-oxadiazole derivatives as potential anti-inflammatory agents by inhibiting NF-κB signaling pathway in LPS-stimulated RAW 264.7 cells. Bioorg Med Chem Lett 2020;30:127373.
   PubMedGoogle Scholar
• Gao J, Liu XG, Zhang B, et al. Design, synthesis and biological evaluation of 1-alkyl-5/6-(5-oxo-4,5-dihydro-1,2,4- oxadiazol-3-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors. Eur J Med Chem 2020;190:112077.
   PubMed Web of Science ®Google Scholar
• Chen YC, Dinavahi SS, Feng QL, et al. Activating Sphingosine-1-phospahte signaling in endothelial cells increases myosin light chain phosphorylation to decrease endothelial permeability thereby inhibiting cancer metastasis. Cancer Lett 2021;506:107–119.
   PubMed Web of Science ®Google Scholar
• Choi HE, Kim YS, Lee HJ, Cheon HG. Novel FoxO1 inhibitor, JY-2, ameliorates palmitic acid-induced lipotoxicity and gluconeogenesis in a murine model. Eur J Pharmacol 2021;899:174011.
   PubMed Web of Science ®Google Scholar
• Mohan G, Sridhar G, Laxminarayana E, Chary MT. Synthesis and biological evaluation of 1,2,4-oxadiazole incorporated 1,2,3-triazole-pyrazole derivatives as anticancer agents. Chem Data Collect 2021;34:100735.
   Google Scholar
• Melo de Oliveira VN, Flávia do Amaral Moura C, Peixoto ADS, et al. Synthesis of alkynylated 1,2,4-oxadiazole/1,2,3-1H -triazole glycoconjugates: discovering new compounds for use in chemotherapy against lung carcinoma and Mycobacterium tuberculosis. Eur J Med Chem 2021;220:113472.
   PubMed Web of Science ®Google Scholar
• Egorova A, Kazakova E, Jahn B, et al. Novel pleconaril derivatives: influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enteroviruses. Eur J Med Chem 2020;188:112007.
   PubMed Web of Science ®Google Scholar
• Sucu BO, Koc EB, Savlug Ipek O, et al. Design and synthesis of novel caffeic acid phenethyl ester (CAPE) derivatives and their biological activity studies in glioblastoma multiforme (GBM) cancer cell lines. J Mol Graph Model 2022;113:108160.
   PubMed Web of Science ®Google Scholar
• Shi JG, Wang Y, Chen JW, et al. Synthesis and biological evaluation of 1,2,4-oxadiazole core derivatives as potential neuroprotectants against acute ischemic stroke. Neurochem Int 2021;148:105103.
   PubMed Web of Science ®Google Scholar
• Kumar Kushwaha P, Saurabh Srivastava K, Kumari N, et al. Synthesis and anti-HIV activity of a new isoxazole containing disubstituted 1,2,4-oxadiazoles analogs. Bioorg Med Chem 2022;56:116612.
   PubMedGoogle Scholar
• Xie HX, Wang YH, Zhang JH, et al. Design, synthesis and biological evaluation of marine phidianidine-inspired derivatives against oxidized LDL-induced endothelial injury by activating Nrf2 anti-oxidation pathway. Bioorg Chem 2022;120:105606.
   PubMed Web of Science ®Google Scholar
• Parrino B, Carbone D, Cascioferro S, et al. 1,2,4-Oxadiazole topsentin analogs as staphylococcal biofilm inhibitors targeting the bacterial transpeptidase Sortase A. Eur J Med Chem 2021;209:112892.
   PubMed Web of Science ®Google Scholar
• Thacker PS, Angeli A, Argulwar OS, et al. Design, synthesis and biological evaluation of coumarin linked 1,2,4-oxadiazoles as selective carbonic anhydrase IX and XII inhibitors. Bioorg Chem 2020;98:103739.
   PubMed Web of Science ®Google Scholar
• Mohamed MFA, Marzouk AA, Nafady A, et al. Design, synthesis and molecular modeling of novel aryl carboximidamides and 3-aryl-1,2,4-oxadiazoles derived from indomethacin as potent anti-inflammatory iNOS/PGE2 inhibitors. Bioorg Chem 2020;105:104439.
   PubMed Web of Science ®Google Scholar
• El Mansouri AE, Oubella A, Maatallah M, et al. Design, synthesis, biological evaluation and molecular docking of new uracil analogs-1,2,4-oxadiazole hybrids as potential anticancer agents. Bioorg Med Chem Lett 2020;30:127438.
   PubMed Web of Science ®Google Scholar
• Fernandes FS, Santos H, Lima SR, et al. Discovery of highly potent and selective antiparasitic new oxadiazole and hydroxy-oxindole small molecule hybrids. Eur J Med Chem 2020;201:112418.
   PubMed Web of Science ®Google Scholar
• Kaur P, Bhat ZR, Bhat S, et al. Synthesis and evaluation of new 1,2,4-oxadiazole based trans-acrylic acid derivatives as potential PPAR-alpha/gamma dual agonist. Bioorg Chem 2020;100:103867.
   PubMed Web of Science ®Google Scholar
• Shamsi F, Hasan P, Queen A, et al. Synthesis and SAR studies of novel 1,2,4-oxadiazole-sulfonamide based compounds as potential anticancer agents for colorectal cancer therapy. Bioorg Chem 2020;98:103754.
   PubMed Web of Science ®Google Scholar
• Wang M, Liu TT, Chen SM, et al. Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents. Eur J Med Chem 2021;209:112874.
   PubMed Web of Science ®Google Scholar
• Qiu H, Ali Z, Bender A, et al. Discovery of potent and selective reversible Bruton’s tyrosine kinase inhibitors. Bioorg Med Chem 2021;40:116163.
   PubMed Web of Science ®Google Scholar
• Frejat FOA, Cao YQ, Zhai HJ, et al. Novel 1,2,4-oxadiazole/pyrrolidine hybrids as DNA gyrase and topoisomerase IV inhibitors with potential antibacterial activity. Arabian J Chem 2022;15:103538.
   Web of Science ®Google Scholar
• Liu TT, Chen SM, Du JY, et al. Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer’s disease. Eur J Med Chem 2022;227:113973.
   PubMed Web of Science ®Google Scholar